Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 100.07%6.41B | -173.30%-9.84T | 36.50%13.43T | -71.81%9.84T | 333.02%34.9T | 43.70%8.06T | -54.44%5.61T | 75.54%12.31T | 3.83%7.01T | 422.29%6.75T |
| Net income from continuing operations | 24.41%2.55T | 30.59%2.05T | 5.37%1.57T | 42.98%1.49T | 25.63%1.04T | -27.58%829.44B | -18.74%1.15T | 8.15%1.41T | -13.05%1.3T | -7.18%1.5T |
| Operating gains losses | 99.24%-40.63B | -154.27%-5.37T | 38.75%-2.11T | -92.50%-3.45T | -11,398.15%-1.79T | 102.33%15.87B | -968.94%-680.8B | 129.96%78.35B | -96.48%34.07B | 161.42%967.7B |
| Depreciation and amortization | 14.53%415.03B | 8.29%362.37B | -7.88%334.64B | 2.19%363.25B | -49.46%355.45B | 106.73%703.29B | 0.41%340.2B | 1.70%338.81B | 5.61%333.15B | -0.78%315.46B |
| Asset impairment expenditure | 355.00%141.54B | 71.23%31.11B | -89.57%18.17B | 322.24%174.13B | -37.31%41.24B | -64.38%65.79B | 142.63%184.69B | 649.08%76.12B | -24.25%10.16B | 16.78%13.42B |
| Other non cashItems | 62.64%-1.16T | 1.21%-3.1T | -73.78%-3.14T | -28.94%-1.81T | 19.45%-1.4T | -9.50%-1.74T | 42.84%-1.59T | -0.64%-2.78T | -42.36%-2.76T | -46.98%-1.94T |
| Change in working capital | 22.82%-4.39T | -139.45%-5.69T | 28.60%14.41T | -67.79%11.21T | 450.39%34.79T | 39.17%6.32T | -60.13%4.54T | 80.28%11.39T | 52.45%6.32T | 238.67%4.14T |
| -Change in receivables | -68.62%-474.54B | -283.15%-281.43B | 115.71%153.66B | -6,294.70%-977.96B | --15.79B | ---- | ---- | ---- | ---- | ---1.44T |
| -Change in payables and accrued expense | 43.06%-2.45T | -283.52%-4.3T | -170.00%-1.12T | 13.67%1.6T | 391.58%1.41T | -382.33%-483.54B | -120.52%-100.25B | 114.36%488.6B | -133.64%-3.4T | 716.77%10.11T |
| -Change in loans | 83.34%-2.14T | -555.72%-12.87T | -12.49%2.82T | -65.64%3.23T | 149.37%9.39T | 89.52%3.77T | -44.58%1.99T | -4.55%3.59T | 156.15%3.76T | -712.50%-6.69T |
| -Change in other current assets | 179.39%517.51B | -1,037.53%-651.88B | 87.88%-57.31B | 16.85%-472.88B | -1,280.26%-568.72B | 99.47%-41.2B | -325.20%-7.72T | 172.24%3.43T | -1,730.04%-4.75T | -86.04%291.29B |
| -Change in other current liabilities | -206.27%-959.12B | 131.71%902.57B | 411.90%389.53B | 166.91%76.1B | -155.78%-113.72B | -118.83%-44.46B | 264.94%236.17B | 180.90%64.71B | -114.76%-79.99B | 44.77%541.83B |
| -Change in other working capital | -94.25%646.03B | -9.24%11.23T | 82.73%12.38T | -72.55%6.77T | 689.58%24.68T | -69.19%3.13T | 165.34%10.14T | -64.58%3.82T | 9,867.76%10.79T | 98.12%-110.49B |
| Interest paid (cash flow from operating activities) | -14.87%-5.57T | -131.16%-4.85T | -284.07%-2.1T | 35.30%-546.5B | 57.02%-844.63B | -11.48%-1.97T | -50.65%-1.76T | -38.08%-1.17T | -29.57%-847.42B | -2.77%-654.03B |
| Interest received (cash flow from operating activities) | 15.70%8.39T | 47.27%7.25T | 85.26%4.92T | -5.80%2.66T | -28.94%2.82T | 6.13%3.97T | 17.59%3.74T | 5.22%3.18T | 4.36%3.02T | -0.68%2.9T |
| Tax refund paid | 37.43%-329.69B | -10.34%-526.91B | -91.50%-477.53B | -123.70%-249.37B | 21.73%-111.47B | 54.59%-142.42B | -43.67%-313.61B | 45.90%-218.29B | 17.78%-403.48B | -12.14%-490.73B |
| Cash from discontinued operating activities | ||||||||||
| Operating cash flow | 100.07%6.42B | -173.30%-9.84T | 36.50%13.43T | -71.81%9.84T | 333.02%34.9T | 43.70%8.06T | -54.44%5.61T | 75.54%12.31T | 3.83%7.01T | 422.29%6.75T |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -104.69%-186.95B | 137.34%3.99T | -384.63%-10.68T | 78.28%-2.2T | -201.04%-10.14T | 40.14%-3.37T | -894.48%-5.63T | -106.35%-565.88B | 297.62%8.91T | -65.54%2.24T |
| Net PPE purchase and sale | -9.96%-56.48B | 28.44%-51.37B | -277.45%-71.79B | 77.48%-19.02B | -49.19%-84.45B | 48.05%-56.6B | 26.40%-108.95B | -64.62%-148.02B | -10.41%-89.92B | 50.34%-81.44B |
| Net intangibles purchas and sale | 3.03%-322.5B | -17.40%-332.59B | -0.66%-283.3B | -10.42%-281.45B | 19.57%-254.9B | -10.98%-316.93B | -15.77%-285.58B | 0.07%-246.68B | -6.66%-246.85B | -3.53%-231.45B |
| Net business purchase and sale | 16.76%-163.41B | 89.00%-196.32B | -158.76%-1.78T | -2,803.08%-689.74B | 97.61%-23.76B | -89,934.36%-995.78B | 84.38%-1.11B | 63.11%-7.08B | -108.78%-19.19B | 226.63%218.64B |
| Net investment purchase and sale | -96.71%151.75B | 153.88%4.61T | -641.63%-8.57T | 87.76%-1.15T | -399.73%-9.43T | 64.12%-1.89T | -22,791.57%-5.26T | -100.24%-22.98B | 308.43%9.41T | -65.74%2.3T |
| Net other investing changes | 522.69%203.7B | -258.43%-48.19B | 152.86%30.42B | 83.30%-57.54B | -208.79%-344.62B | -487.57%-111.6B | 120.41%28.8B | 5.30%-141.11B | -598.47%-149.01B | -69.02%29.89B |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -104.69%-186.95B | 137.34%3.99T | -384.63%-10.68T | 78.28%-2.2T | -201.04%-10.14T | 40.14%-3.37T | -894.49%-5.63T | -106.35%-565.88B | 297.62%8.91T | -65.54%2.24T |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -10,464.89%-861.12B | 100.85%8.31B | 9.56%-977.14B | -147.76%-1.08T | -73.28%-436.07B | 48.04%-251.66B | -66.71%-484.36B | 56.67%-290.54B | -535.01%-670.59B | 90.87%-105.6B |
| Net issuance payments of debt | -75.21%221.07B | 865.38%891.73B | 79.32%-116.51B | -413.52%-563.39B | -123.84%-109.71B | 117.43%460.2B | -47.27%211.66B | 17.77%401.44B | -23.27%340.87B | 489.28%444.26B |
| Net commonstock issuance | -1.26%-402.89B | 11.18%-397.86B | -192.53%-447.92B | -7,288.54%-153.12B | 104.46%2.13B | 69.36%-47.73B | 21.66%-155.76B | 8.65%-198.83B | -9.39%-217.66B | 59.40%-198.97B |
| Net preferred stock issuance | ---- | ---- | ---- | ---- | ---- | -48.65%-330B | -48.00%-222B | 68.01%-150B | ---468.96B | --0 |
| Cash dividends paid | -21.20%-532.98B | -15.59%-439.76B | -13.70%-380.45B | -3.99%-334.62B | -5.66%-321.77B | -10.23%-304.54B | -14.61%-276.28B | 2.23%-241.07B | 1.96%-246.56B | 4.73%-251.5B |
| Net other financing activities | -219.41%-146.32B | -41.97%-45.81B | -10.11%-32.27B | -336.27%-29.3B | 77.31%-6.72B | 29.48%-29.6B | 58.88%-41.98B | -30.41%-102.08B | 21.25%-78.28B | 34.21%-99.39B |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -10,466.15%-861.12B | 100.85%8.31B | 9.56%-977.14B | -147.76%-1.08T | -73.28%-436.07B | 48.04%-251.66B | -66.71%-484.36B | 56.67%-290.54B | -535.02%-670.59B | 90.87%-105.6B |
| Net cash flow | ||||||||||
| Beginning cash position | -3.30%109.88T | 2.59%113.63T | 7.56%110.76T | 31.46%102.98T | 5.56%78.34T | -0.68%74.21T | 17.61%74.71T | 238.55%63.53T | 87.83%18.76T | 53.98%9.99T |
| Current changes in cash | 82.19%-1.04T | -428.74%-5.85T | -72.86%1.78T | -73.05%6.56T | 447.85%24.33T | 983.55%4.44T | -104.39%-502.6B | -24.89%11.45T | 71.56%15.25T | 173.57%8.89T |
| Effect of exchange rate changes | -87.47%261.99B | 91.90%2.09T | -11.36%1.09T | 288.22%1.23T | 201.46%316.54B | -7,342.56%-311.99B | 98.43%-4.19B | -486.15%-266.62B | 60.52%-45.49B | -145.58%-115.21B |
| Cash adjustments other than cash changes | --0 | 341.84%4.6B | 39.47%-1.9B | ---3.14B | --0 | ---- | ---- | ---- | ---- | ---- |
| End cash position | -0.71%109.1T | -3.30%109.88T | 2.59%113.63T | 7.56%110.76T | 31.46%102.98T | 5.56%78.34T | -0.68%74.21T | 119.95%74.71T | 81.03%33.97T | 87.83%18.76T |
| Free cash from | 95.63%-450.29B | -179.11%-10.31T | 37.80%13.03T | -72.60%9.46T | 353.17%34.51T | 46.98%7.61T | -56.48%5.18T | 79.23%11.9T | 3.68%6.64T | 356.68%6.41T |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |